scholarly journals Polymeric Nanoparticles for Mitochondria Targeting Mediated Robust Cancer Therapy

2021 ◽  
Vol 9 ◽  
Author(s):  
Yajing Sun ◽  
Qingshan Yang ◽  
Xue Xia ◽  
Xiaozhe Li ◽  
Weimin Ruan ◽  
...  
Keyword(s):  
Cancer Therapy ◽  
Polymeric Nanoparticles ◽  
Membrane System ◽  
Therapeutic Agents ◽  
Treatment Efficiency ◽  
Design And Synthesis ◽  
The Past ◽  
Promising Strategy ◽  
Anticancer Treatment ◽  
Mitochondria Targeting

Despite all sorts of innovations in medical researches over the past decades, cancer remains a major threat to human health. Mitochondria are essential organelles in eukaryotic cells, and their dysfunctions contribute to numerous diseases including cancers. Mitochondria-targeted cancer therapy, which specifically delivers drugs into the mitochondria, is a promising strategy for enhancing anticancer treatment efficiency. However, owing to their special double-layered membrane system and highly negative potentials, mitochondria remain a challenging target for therapeutic agents to reach and access. Polymeric nanoparticles exceed in cancer therapy ascribed to their unique features including ideal biocompatibility, readily design and synthesis, as well as flexible ligand decoration. Significant efforts have been put forward to develop mitochondria-targeted polymeric nanoparticles. In this review, we focused on the smart design of polymeric nanosystems for mitochondria targeting and summarized the current applications in improving cancer therapy.

scholarly journals Mitochondria-Targeted Nanocarriers Promote Highly Efficient Cancer Therapy: A Review

2021 ◽  
Vol 9 ◽  
Author(s):  
Zeng Zeng ◽  
Chao Fang ◽  
Ying Zhang ◽  
Cong-Xian Chen ◽  
Yi-Feng Zhang ◽  
...  
Keyword(s):  
Cancer Therapy ◽  
Cancer Treatment ◽  
Therapeutic Agents ◽  
Sonodynamic Therapy ◽  
Therapeutic Modalities ◽  
Normal Functions ◽  
The Past ◽  
Highly Efficient ◽  
Apoptotic Pathways ◽  
Mitochondria Targeting

Mitochondria are the primary organelles which can produce adenosine triphosphate (ATP). They play vital roles in maintaining normal functions. They also regulated apoptotic pathways of cancer cells. Given that, designing therapeutic agents that precisely target mitochondria is of great importance for cancer treatment. Nanocarriers can combine the mitochondria with other therapeutic modalities in cancer treatment, thus showing great potential to cancer therapy in the past few years. Herein, we summarized lipophilic cation- and peptide-based nanosystems for mitochondria targeting. This review described how mitochondria-targeted nanocarriers promoted highly efficient cancer treatment in photodynamic therapy (PDT), chemotherapy, combined immunotherapy, and sonodynamic therapy (SDT). We further discussed mitochondria-targeted nanocarriers’ major challenges and future prospects in clinical cancer treatment.

scholarly journals Polymeric Co-Delivery Systems in Cancer Treatment: An Overview on Component Drugs’ Dosage Ratio Effect

Molecules ◽  
2019 ◽  
Vol 24 (6) ◽  
pp. 1035 ◽  
Author(s):  
Jiayi Pan ◽  
Kobra Rostamizadeh ◽  
Nina Filipczak ◽  
Vladimir Torchilin
Keyword(s):  
Cancer Therapy ◽  
Cancer Treatment ◽  
Therapeutic Agent ◽  
Polymeric Nanoparticles ◽  
Therapeutic Agents ◽  
Delivery Systems ◽  
Individual Therapy ◽  
Multiple Factors ◽  
Therapeutic Outcomes ◽  
Anti Cancer

Multiple factors are involved in the development of cancers and their effects on survival rate. Many are related to chemo-resistance of tumor cells. Thus, treatment with a single therapeutic agent is often inadequate for successful cancer therapy. Ideally, combination therapy inhibits tumor growth through multiple pathways by enhancing the performance of each individual therapy, often resulting in a synergistic effect. Polymeric nanoparticles prepared from block co-polymers have been a popular platform for co-delivery of combinations of drugs associated with the multiple functional compartments within such nanoparticles. Various polymeric nanoparticles have been applied to achieve enhanced therapeutic efficacy in cancer therapy. However, reported drug ratios used in such systems often vary widely. Thus, the same combination of drugs may result in very different therapeutic outcomes. In this review, we investigated polymeric co-delivery systems used in cancer treatment and the drug combinations used in these systems for synergistic anti-cancer effect. Development of polymeric co-delivery systems for a maximized therapeutic effect requires a deeper understanding of the optimal ratio among therapeutic agents and the natural heterogenicity of tumors.

Subcellular co-delivery of two different site-oriented payloads based on multistage targeted polymeric nanoparticles for enhanced cancer therapy

2018 ◽  
Vol 6 (42) ◽  
pp. 6752-6766 ◽  
Author(s):  
Chao-Qun You ◽  
Hong-Shuai Wu ◽  
Zhi-Guo Gao ◽  
Kai Sun ◽  
Fang-Hui Chen ◽  
...  
Keyword(s):  
Cancer Therapy ◽  
Targeted Delivery ◽  
Polymeric Nanoparticles ◽  
Therapeutic Agents ◽  
Antitumor Therapy

Smart nanoparticles which encapsulated two different site-oriented therapeutic agents for multistage targeted delivery and enhanced antitumor therapy.

scholarly journals Polydopamine-Based “Four-in-One” Versatile Nanoplatforms for Targeted Dual Chemo and Photothermal Synergistic Cancer Therapy

Pharmaceutics ◽  
2019 ◽  
Vol 11 (10) ◽  
pp. 507 ◽  
Author(s):  
Liu ◽  
Gao ◽  
Zhou ◽  
Nie ◽  
Cheng ◽  
...  
Keyword(s):  
Cancer Therapy ◽  
Anticancer Drug ◽  
Near Infrared ◽  
Polymeric Nanoparticles ◽  
Carcinoma Cells ◽  
Promising Strategy ◽  
Human Breast Carcinoma Cells ◽  
Mcf 7

Abstract: The development of versatile nanoscale drug delivery systems that integrate with multiple therapeutic agents or methods and improve the efficacy of cancer therapy is urgently required. To satisfy this demand, polydopamine (PDA)-modified polymeric nanoplatforms were constructed for the dual loading of chemotherapeutic drugs. The hydrophobic anticancer drug docetaxel (DTX) was loaded into the polymeric nanoparticles (NPs) which were fabricated from the star-shaped copolymer CA-PLGA. Then DTX-loaded NPs were coated with PDA, followed by conjugation of polyelethyl glycol (PEG)-modified targeting ligand aptamer AS1411(Apt) and adsorption of the hydrophilic anticancer drug doxorubicin (DOX). This “four-in-one” nanoplatform, referred to as DTX/NPs@PDA/DOX-PEG-Apt, demonstrated high near-infrared photothermal conversion efficiency and exhibited pH and thermo-responsive drug release behavior. Furthermore, it was able to specifically target MCF-7 human breast carcinoma cells and provide synergistic chemo-photothermal therapy to further improve the anticancer effect both in vitro and in vivo, providing a novel promising strategy for cancer therapy.

Organelle-targeted photothermal agents for cancer therapy

2021 ◽  
Author(s):  
Eunbin Hwang ◽  
Hyo Sung Jung
Keyword(s):  
Cancer Therapy ◽  
Photothermal Therapy ◽  
Rapid Development ◽  
Therapeutic Agents ◽  
The Past

Over the past ten years, advances in the field of organelle-targeted photothermal therapy (PTT) have stimulated the rapid development of organelle-targeted PTT agents as anticancer therapeutic agents. However, to the...

scholarly journals A review on application of nanoparticles for cancer therapy

2019 ◽  
Vol 5 (2) ◽  
pp. e17-e17
Author(s):  
Mohamad Ali Dayani
Keyword(s):  
Cancer Therapy ◽  
Polymeric Nanoparticles ◽  
Scientific Societies ◽  
The Past ◽  
Profound Influence ◽  
Biomedical Fields

In recent years, scientific societies had warmly embraced nanotechnology as an emerging field in cancer therapy. Nanotechnology has had a profound influence on almost every aspect of the twenty-first century’s diurnal life. During the past years, nanomaterials have been successfully applied in different biomedical fields; especially in cancer therapy. While cancer is one of the deadliest disorders worldwide, there is a need to develop novel anticancer approaches. In this review, we explained various kinds of nanoparticles such as liposome-based and polymeric nanoparticles and dendrimers along with their applications in cancer therapy.

Environment-responsive Polymeric Nanoparticles as Drug Delivery Systems for Cancer Therapy

2013 ◽  
Vol 40 (10) ◽  
pp. 1039
Author(s):  
Yang YANG ◽  
Wen-Chuan SHE ◽  
Kui LUO ◽  
Zhong-Wei GU
Keyword(s):  
Drug Delivery ◽  
Cancer Therapy ◽  
Drug Delivery Systems ◽  
Polymeric Nanoparticles ◽  
Delivery Systems

Chinese Medicine Protein and Peptide in Gene and Cell Therapy

2019 ◽  
Vol 20 (3) ◽  
pp. 251-264 ◽  
Author(s):  
Yinlu Feng ◽  
Zifei Yin ◽  
Daniel Zhang ◽  
Arun Srivastava ◽  
Chen Ling
Keyword(s):  
Chinese Medicine ◽  
Cell Therapy ◽  
Future Research ◽  
The Past ◽  
Promising Strategy ◽  
Wide Range ◽  
New Directions ◽  
Gene And Cell Therapy ◽  
Proteins And Peptides

The success of gene and cell therapy in clinic during the past two decades as well as our expanding ability to manipulate these biomaterials are leading to new therapeutic options for a wide range of inherited and acquired diseases. Combining conventional therapies with this emerging field is a promising strategy to treat those previously-thought untreatable diseases. Traditional Chinese medicine (TCM) has evolved for thousands of years in China and still plays an important role in human health. As part of the active ingredients of TCM, proteins and peptides have attracted long-term enthusiasm of researchers. More recently, they have been utilized in gene and cell therapy, resulting in promising novel strategies to treat both cancer and non-cancer diseases. This manuscript presents a critical review on this field, accompanied with perspectives on the challenges and new directions for future research in this emerging frontier.

Oleanolic Acid Derived from Plants: Synthesis and Pharmacological Properties of A-ring Modified Derivatives

2020 ◽  
Vol 17 (9) ◽  
pp. 1084-1101
Author(s):  
Tingjuan Wu ◽  
Xu Yao ◽  
Guan Wang ◽  
Xiaohe Liu ◽  
Hongfei Chen ◽  
...  
Keyword(s):  
Drug Design ◽  
Oleanolic Acid ◽  
Water Solubility ◽  
Future Application ◽  
The Novel ◽  
Pharmacological Effects ◽  
Framework Structure ◽  
Design And Synthesis ◽  
The Past ◽  
The Relationship

Background: Oleanolic Acid (OA) is a ubiquitous product of triterpenoid compounds. Due to its inexpensive availability, unique bioactivities, pharmacological effects and non-toxic properties, OA has attracted tremendous interest in the field of drug design and synthesis. Furthermore, many OA derivatives have been developed for ameliorating the poor water solubility and bioavailability. Objective: Over the past few decades, various modifications of the OA framework structure have led to the observation of enhancement in bioactivity. Herein, we focused on the synthesis and medicinal performance of OA derivatives modified on A-ring. Moreover, we clarified the relationship between structures and activities of OA derivatives with different functional groups in A-ring. The future application of OA in the field of drug design and development also was discussed and inferred. Conclusion: This review concluded the novel achievements that could add paramount information to the further study of OA-based drugs.

Sign in / Sign up

Export Citation Format

Share Document